Skip to main content
Signal8

Pauling David

SEC insider (Form 3/4/5 filer). CIK 0002063633. Chief Admin. Ofcr. & GC at SUTRO BIOPHARMA, INC. (STRO). 13 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Pauling David has filed insider reports for

  • SUTRO BIOPHARMA, INC. (STRO): Officer, Chief Admin. Ofcr. & GC
Pauling David profile photo

Pauling David

CIK: 0002063633

Transaction Breakdown

Open Market Buys (P)1 (7.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (30.8%)

Derivative conversions

Awards (A)5 (38.5%)

Compensation grants

Other (G, F, J, C, D, …)3 (23.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SUTRO BIOPHARMA, INC. logo
STRO

SUTRO BIOPHARMA, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 4, 2026
    Exercise
    Direct
    675 shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 4, 2026
    Tax Payment
    Direct
    277 shares at avg. $21.31$6K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 2, 2026
    Award

    Stock Option (right to buy)

    Direct
    33.6K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 2, 2026
    Exercise
    Direct
    2.4K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 2, 2026
    Tax Payment
    Direct
    970 shares at avg. $20.55$20K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 2, 2026
    Award

    Restricted Stock Units (RSUs)

    Direct
    4.2K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 1, 2026
    Exercise
    Direct
    500 shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 1, 2026
    Exercise
    Direct
    842 shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 1, 2026
    Tax Payment
    Direct
    551 shares at avg. $20.47$11K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Dec 23, 2025
    Award

    Stock Option (right to buy)

    Direct
    7.2K shares-

1-10 of 13